Precision medicine in oncology is continually evolving, with recent advances in epigenetics presenting
new pathways for understanding and treating cancer more effectively. Epigenetics involves the study of
heritable changes in gene expression that do not involve alterations to the underlying DNA sequence —
essentially, how genes are turned on or off. This blog post delves into how epigenetic factors are being
integrated into oncology to refine cancer treatment, enhance predictive capabilities, and offer new
therapeutic targets.
The Expanding Role of Epigenetics in Cancer Care
Epigenetics is reshaping our understanding of cancer by highlighting how environmental factors and
lifestyle choices can influence gene expression and, by extension, cancer progression and response to
treatment. Key components of epigenetic changes include DNA methylation, histone modification, and
the role of non-coding RNAs, all of which can affect how genes are expressed in cancer cells.
Read the full blog below: